Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids

Since the start of the COVID-19 global pandemic, our understanding of the underlying disease mechanism and factors associated with the disease severity has dramatically increased. A recent study investigated the relationship between substance use disorders (SUD) and the risk of severe COVID-19 in th...

Full description

Bibliographic Details
Main Authors: M. Reza Jabalameli, Zhengdong D. Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.1070428/full
_version_ 1811295059678593024
author M. Reza Jabalameli
Zhengdong D. Zhang
author_facet M. Reza Jabalameli
Zhengdong D. Zhang
author_sort M. Reza Jabalameli
collection DOAJ
description Since the start of the COVID-19 global pandemic, our understanding of the underlying disease mechanism and factors associated with the disease severity has dramatically increased. A recent study investigated the relationship between substance use disorders (SUD) and the risk of severe COVID-19 in the United States and concluded that the risk of hospitalization and death due to COVID-19 is directly correlated with substance abuse, including opioid use disorder (OUD) and cannabis use disorder (CUD). While we found this analysis fascinating, we believe this observation may be biased due to comorbidities (such as hypertension, diabetes, and cardiovascular disease) confounding the direct effect of SUD on severe COVID-19 illness. To answer this question, we sought to investigate the causal relationship between substance abuse and medication-taking history (as a proxy trait for comorbidities) with the risk of COVID-19 adverse outcomes. Our Mendelian randomization analysis confirms the causal relationship between OUD and severe COVID-19 illness but suggests an inverse causal effect for cannabinoids. Considering that COVID-19 mortality is largely attributed to disturbed immune regulation, the possible modulatory impact of cannabinoids in alleviating cytokine storms merits further investigation.
first_indexed 2024-04-13T05:27:44Z
format Article
id doaj.art-8e8bff32dfda4ecba597c2d461a90014
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-13T05:27:44Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-8e8bff32dfda4ecba597c2d461a900142022-12-22T03:00:33ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-12-011310.3389/fgene.2022.10704281070428Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoidsM. Reza JabalameliZhengdong D. ZhangSince the start of the COVID-19 global pandemic, our understanding of the underlying disease mechanism and factors associated with the disease severity has dramatically increased. A recent study investigated the relationship between substance use disorders (SUD) and the risk of severe COVID-19 in the United States and concluded that the risk of hospitalization and death due to COVID-19 is directly correlated with substance abuse, including opioid use disorder (OUD) and cannabis use disorder (CUD). While we found this analysis fascinating, we believe this observation may be biased due to comorbidities (such as hypertension, diabetes, and cardiovascular disease) confounding the direct effect of SUD on severe COVID-19 illness. To answer this question, we sought to investigate the causal relationship between substance abuse and medication-taking history (as a proxy trait for comorbidities) with the risk of COVID-19 adverse outcomes. Our Mendelian randomization analysis confirms the causal relationship between OUD and severe COVID-19 illness but suggests an inverse causal effect for cannabinoids. Considering that COVID-19 mortality is largely attributed to disturbed immune regulation, the possible modulatory impact of cannabinoids in alleviating cytokine storms merits further investigation.https://www.frontiersin.org/articles/10.3389/fgene.2022.1070428/fullMendelian randomizationsubstance use disorderGWAScannabinoidsinflammation
spellingShingle M. Reza Jabalameli
Zhengdong D. Zhang
Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids
Frontiers in Genetics
Mendelian randomization
substance use disorder
GWAS
cannabinoids
inflammation
title Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids
title_full Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids
title_fullStr Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids
title_full_unstemmed Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids
title_short Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids
title_sort substance abuse and the risk of severe covid 19 mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids
topic Mendelian randomization
substance use disorder
GWAS
cannabinoids
inflammation
url https://www.frontiersin.org/articles/10.3389/fgene.2022.1070428/full
work_keys_str_mv AT mrezajabalameli substanceabuseandtheriskofseverecovid19mendelianrandomizationconfirmsthecausalroleofopioidsbuthintsanegativecausaleffectforcannabinoids
AT zhengdongdzhang substanceabuseandtheriskofseverecovid19mendelianrandomizationconfirmsthecausalroleofopioidsbuthintsanegativecausaleffectforcannabinoids